Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Flynn, J. Articles by Benedek, D. M. Search for Related Content PubMed Citation Articles by Flynn, J. Articles by Benedek, D. M. Hospitals, Hospital Treatment Atypical Neuroleptics Conventional Neuroleptics Schizophrenia Spectrum Disorders

Pharmacologic Treatment of Hospitalized Patients With Schizoaffective Disorder

This study examined changes in the pharmacologic treatment of 70 patients who were hospitalized with a diagnosis of schizoaffective disorder at some time during a six-year period. An increasing use of divalproex sodium and atypical antipsychotics instead of lithium and conventional antipsychotics was observed. The use of a combination of an antipsychotic and a thymoleptic medication was more common than monotherapy, and physicians tended to continue antidepressants if patients had a history of depression. Patients with a new diagnosis of schizoaffective disorder were stabilized less quickly than those with a previous diagnosis. The use of divalproex sodium and newer antipsychotics did not reduce the time to stabilization in routine clinical practice.

This article has been cited by other articles:

				M. Olfson, S. C. Marcus, and G. J. Wan Treatment Patterns for Schizoaffective Disorder and Schizophrenia Among Medicaid Patients Psychiatr Serv, February 1, 2009; 60(2): 210 - 216. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2002 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us